Professional
Added to YB: 2026-04-27
Pitch date: 2026-03-31
MCK [neutral]
McKesson Corporation
-2.46%
current return
Author Info
No bio for this author
Company Info
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$89.4B
Pitch Price
$862.13
Price Target
N/A
Dividend
0.43%
EV/EBITDA
12.86
P/E
19.90
EV/Sales
0.24
Sector
Health Care Providers and Services
Category
special_situation
Conventum - Alluvium Global Fund Portfolio Holding: McKesson Corporation
MCK (holding update): Drug distributor +5.6% in Q4. Mgmt raised/tightened FY guidance, completed EU business divestment, plans Medical Surgical separation, reiterated mid-teens LT growth outlook. Share price +15.7% on day. Valuation raised ~5% after tweaks. Remains sizeable Fund position.
Read full article (1 min)